Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 18, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
Confirmation of COVID-19 in Two Pet Cats in New York
admin
-
April 23, 2020
0
Latest Pharma-News
Hard fought gains in immunization coverage at risk without critical health services, warns WHO
admin
-
April 23, 2020
0
Latest Pharma-News
Novartis announces new Mayzent® (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis...
admin
-
April 22, 2020
0
Latest Pharma-News
Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments
admin
-
April 22, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection
admin
-
April 22, 2020
0
Latest Pharma-News
Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19
admin
-
April 22, 2020
0
Latest Pharma-News
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
admin
-
April 22, 2020
0
Latest Pharma-News
UN agencies issue urgent call to fund the global emergency supply system to fight COVID-19
admin
-
April 22, 2020
0
Latest Pharma-News
New study to explore the effects of social distancing launched online
admin
-
April 21, 2020
0
Latest Pharma-News
Five Oxford COVID-19 projects receive UKRI funding
admin
-
April 21, 2020
0
Latest Pharma-News
Alembic Pharmaceuticals announces USFDA Tentative Approval for Alcaftadine Ophthalmic Solution, 0.25%.
admin
-
April 21, 2020
1
Latest Pharma-News
Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignant...
admin
-
April 21, 2020
0
1
...
119
120
121
...
144
Page 120 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024